Engineering synthetic bacteriophage to combat antibiotic-resistant bacteria

Proceedings of the IEEE Annual Northeast Bioengineering Conference, NEBEC

Volumn , Issue , 2009, Pages

  Lu, T K ^a,b   Collins, J J ^b  

^a HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^b Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; BACTERIOLOGY; BACTERIOPHAGES; GENES; MAMMALS; SYNTHETIC BIOLOGY;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC-RESISTANT BACTERIA; ANTIMICROBIAL DRUG; BACTERIAL KILLING; GENE NETWORKS; MULTIPLE FACTORS; ORDERS OF MAGNITUDE; QUINOLONE ANTIBIOTICS;

ANTIBIOTICS;

EID: 70349108032     PISSN: 1071121X     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/NEBC.2009.4967831     Document Type: Conference Paper

References (15)

1. C. Walsh, "Where will new antibiotics come from?," Nat Rev Microbiol, vol.1, no.1, pp. 65-70, Oct, 2003.
2. M. A. Kohanski, D. J. Dwyer, B. Hayete et al., "A common mechanism of cellular death induced by bactericidal antibiotics," Cell, vol.130, no.5, pp. 797-810, Sep, 2007.
3. M. A. Kohanski, D. J. Dwyer, J. Wierzbowski et al., "Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death," Cell, vol.135, no.4, pp. 679-690, Nov 14, 2008.
4. C. R. Merril, D. Scholl, and S. L. Adhya, "The prospect for bacteriophage therapy in Western medicine," Nat Rev Drug Discov, vol.2, no.6, pp. 489-497, Jun, 2003.
5. T. K. Lu, and J. J. Collins, "Dispersing biofilms with engineered enzymatic bacteriophage," Proc Natl Acad Sci USA, vol.104, no.27, pp. 11197-11202, Jul, 2007.
6. R. Chait, A. Craney, and R. Kishony, "Antibiotic interactions that select against resistance," Nature, vol.446, no.7136, pp. 668-671 , Apr, 2007.
7. S. B. Levy, and B. Marshall, "Antibacterial resistance worldwide: causes, challenges and responses," Nat Med, vol.10, no.12 Suppl, pp. S122-S129, Dec, 2004.
8. S. Hagens, A. Habel, and U. Bläsi, "Augmentation of the antimicrobial efficacy of antibiotics by filamentous phage," Microb Drug Resist, vol.12, no.3, pp. 164-168, 2006.
9. C. S. Lewin, B. M. Howard, N. T. Ratcliffe et al., "4-quinolones and the SOS response," J Med Microbiol, vol.29, no.2, pp. 139-144, Jun, 1989.
10. J. W. Little, and J. E. Harper, "Identification of the lexA gene product of Escherichia coli K-12," Proc Natl Acad Sci USA, vol.76, no.12, pp. 6147-6151 , Dec, 1979.
11. C. Yanisch-Perron, J. Vieira, and J. Messing, "Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors," Gene, vol.33, no.1, pp. 103-119, 1985.
12. R. Lutz, and H. Bujard, "Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements," Nucleic Acids Res, vol.25, no.6, pp. 1203-1210, Mar, 1997.
13. T. K. Lu, and J. J. Collins, "Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy," Proc Natl Acad Sci USA, under review.
14. J. B. Stewart, C. Freyer, J. L. Elson et al., "Strong purifying selection in transmission of mammalian mitochondrial DNA," PLoS Biol, vol.6, no.1, pp. e1O, Jan, 2008.
15. D. Baker, G. Church, J. Collins et al., "Engineering life: building a fab for biology," Sci Am, vol.294, no.6, pp. 44-51, Jun, 2006.